Huntsville, Ala. – Four scientists at the HudsonAlpha Institute for Biotechnology made Clarivate Analytics’ 2018 list of Highly Cited Researchers. The list requires a citation count that ranks a researcher in the top 1% in their field.
The 2018 list aims to identify the “small fraction of the researcher population that contributes disproportionately” to the advancement of science. It measured influence across 21 different fields from 2006-2016.
HudsonAlpha President and Faculty Investigator Richard M. Myers, PhD, made this list for his work in Molecular Biology & Genetics. Specifically, Myers has recently published advancements in understanding psychiatric and neurodegenerative diseases. His work has explored the genetic underpinnings of illnesses including schizophrenia, depression and Alzheimer disease.
Devin Absher, PhD, a faculty investigator, was also put on the list for his contributions in Molecular Biology & Genetics. Absher focuses on epigenetics, the study of what leads some genes to be expressed more than others. That research covers a broad range of human health, from heart disease to cancer.
Faculty investigators Jeremy Schmutz and Jane Grimwood, PhD, were both recognized for their work as well, much of which stems from the Genome Sequencing Center (HGSC) at the Institute, which they co-direct. Their research focuses on developing our understanding of agricultural genomics, pushing us closer to the foods and biofuels of the future. Schmutz was listed specifically for his contributions in Plant & Animal Science. Grimwood was listed as having Cross-Field contributions.
“It’s gratifying to have the quality of our researchers recognized by this list,” said Myers, “But we’re also extremely proud that our work has proven foundational to other researchers. We continue to strive not only to push boundaries ourselves but also to lay the groundwork for even more scientific discovery.”
About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha’s vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. The state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education and includes more than 30 diverse biotech companies on campus. To learn more about HudsonAlpha, visit hudsonalpha.org.